AccessHealth MA (Site 1419)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• HIV

Running trials

• Active, not recruiting

  A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

  NCT05630755· Phase 3· Merck Sharp & Dohme LLC· Source